Pamela T. Lee

Pamela T. Lee supports the Food and Drug Administration’s Office of Acquisition and Grant Services in executing mission-critical procurement activities that sustain regulatory science and public health infrastructure. She manages a diverse portfolio of contracts focused on scientific consulting, laboratory operations, and technical services essential to the FDA’s oversight of drugs, biologics, and medical devices. Her work ensures the agency maintains high-precision analytical capabilities and robust research support systems, aligning procurement decisions with strategic priorities in regulatory science and public health program administration. Lee maintains consistent working relationships with specialized contractors including Tranquil Clinical and Research Consulting Services LLC, Toxicologic Pathology Associates Inc., and Progenics Pharmaceuticals Inc., reflecting a preference for niche providers with deep expertise in preclinical research, toxicology, and clinical trial support. These partnerships are typically non-commercial, science-driven engagements that require technical rigor and regulatory alignment, often involving custom service delivery rather than off-the-shelf solutions. Her contracting approach emphasizes vendor qualifications, scientific credibility, and compliance with federal standards for research integrity. Her procurement patterns show a strong orientation toward open competition, with 81.8% of awards issued without set-aside restrictions, while maintaining a meaningful 18.2% commitment to total small business set-asides under FAR 19.5. This balance reflects a strategic emphasis on access to specialized capabilities while ensuring opportunities for qualified small businesses, particularly those with scientific and technical expertise in public health domains. Lee’s primary NAICS focus areas include 541990 and 541690 for professional scientific consulting, 923120 for public health program administration, and 611430 for professional training services. These reflect her core procurement domain: securing expert services that support FDA’s scientific review, laboratory operations, and workforce development, with a clear emphasis on technical precision and regulatory compliance in life sciences.